Literature DB >> 21296979

Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus.

Zhan Huang1, Binqing Fu, Song Guo Zheng, Xiaomei Li, Rui Sun, Zhigang Tian, Haiming Wei.   

Abstract

Dysfunction of immune systems, including innate and adaptive immunity, is responsible for the immunopathogenesis of systemic lupus erythematosus (SLE). NK cells are a major part of the innate immune system, and diminished populations of NK cells have been reported in SLE patients. However, the mechanisms behind this decrease and the role of NK cells in SLE pathogenesis remain poorly understood. In this study, we found that a deficiency of NK cells, especially CD226(+) NK cells, is prominent in patients with active SLE. Meanwhile, expression of the CD226 ligands CD112 and CD155 on plasmacytoid dendritic cells is observed in SLE patients; thus, activation of CD226(+) NK cells may be induced by CD226-ligand interactions. Furthermore, IFN-α, which is mainly produced by plasmacytoid dendritic cells, can mediate the activation-induced cell death of NK cells. Therefore, these processes likely contribute to the loss of NK cells in patients with active SLE. Despite the impaired cytotoxicity of peripheral NK cells in human SLE patients and mouse SLE models, we provide evidence that CD226(+) NK cells infiltrate the kidneys of predisease MRL-lpr/lpr mice. Kidney-infiltrating NK cells displayed an activated phenotype and a marked ability to produce cytotoxic granules. These results suggest that, before apoptosis, activated NK cells can infiltrate tissues and, to some extent, mediate tissue injury by producing cytotoxic granules and immunoregulatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296979      PMCID: PMC3097030          DOI: 10.4049/jimmunol.1000569

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus.

Authors:  Viktoria M Rönnefarth; Annika I M Erbacher; Tobias Lamkemeyer; Johannes Madlung; Alfred Nordheim; Hans-Georg Rammensee; Patrice Decker
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 2.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

3.  B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation.

Authors:  Jun Yan; Bohdan P Harvey; Renelle J Gee; Mark J Shlomchik; Mark J Mamula
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

4.  Autoantigen-B cell antigen receptor interactions that regulate expression of B cell antigen receptor Loci.

Authors:  Xiaohe Liu; Lawrence J Wysocki; Tim Manser
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

5.  Systemic lupus erythematosus: a matter of life and death.

Authors:  David S Pisetsky; Lars Rönnblom
Journal:  Arthritis Rheum       Date:  2009-06

Review 6.  Functions of natural killer cells.

Authors:  Eric Vivier; Elena Tomasello; Myriam Baratin; Thierry Walzer; Sophie Ugolini
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

Review 7.  Systemic lupus erythematosus: all roads lead to type I interferons.

Authors:  Virginia Pascual; Lorant Farkas; Jacques Banchereau
Journal:  Curr Opin Immunol       Date:  2006-10-02       Impact factor: 7.486

8.  The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.

Authors:  Yasser M El-Sherbiny; Josephine L Meade; Tim D Holmes; Dennis McGonagle; Sarah L Mackie; Ann W Morgan; Gordon Cook; Sylvia Feyler; Stephen J Richards; Faith E Davies; Gareth J Morgan; Graham P Cook
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

9.  Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.

Authors:  Anna-Marie Fairhurst; Chun Xie; Yuyang Fu; Andrew Wang; Christopher Boudreaux; Xin J Zhou; Ricardo Cibotti; Anthony Coyle; John E Connolly; Edward K Wakeland; Chandra Mohan
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

10.  Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.

Authors:  Yong-Wook Park; Seung-Jung Kee; Young-Nan Cho; Eun-Hee Lee; Hwa-Youn Lee; Eun-Mi Kim; Min-Ho Shin; Jeong-Jin Park; Tae-Jong Kim; Shin-Seok Lee; Dae-Hyun Yoo; Hyung-Sik Kang
Journal:  Arthritis Rheum       Date:  2009-06
View more
  25 in total

1.  NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.

Authors:  Roberto Spada; José M Rojas; Sonia Pérez-Yagüe; Vladimir Mulens; Pablo Cannata-Ortiz; Rafael Bragado; Domingo F Barber
Journal:  J Leukoc Biol       Date:  2015-01-12       Impact factor: 4.962

Review 2.  Expanding the B Cell-Centric View of Systemic Lupus Erythematosus.

Authors:  Peter A Morawski; Silvia Bolland
Journal:  Trends Immunol       Date:  2017-03-06       Impact factor: 16.687

3.  Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus.

Authors:  K Hudspeth; S Wang; J Wang; S Rahman; M A Smith; K A Casey; Z Manna; M Sanjuan; R Kolbeck; S Hasni; R Ettinger; R M Siegel
Journal:  Clin Exp Immunol       Date:  2019-03-19       Impact factor: 4.330

Review 4.  Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus.

Authors:  Alexandros P Grammatikos; George C Tsokos
Journal:  Trends Mol Med       Date:  2011-12-15       Impact factor: 11.951

5.  NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.

Authors:  Ana Henriques; Luís Teixeira; Luís Inês; Tiago Carvalheiro; Ana Gonçalves; António Martinho; Maria Luísa Pais; José António Pereira da Silva; Artur Paiva
Journal:  Clin Rheumatol       Date:  2013-02-02       Impact factor: 2.980

6.  Activation status of CD56dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus.

Authors:  Manman Liu; Junli Liu; Xiaoyan Zhang; Yichuan Xiao; Gengru Jiang; Xinfang Huang
Journal:  Clin Rheumatol       Date:  2020-08-14       Impact factor: 2.980

Review 7.  Subsets of human natural killer cells and their regulatory effects.

Authors:  Binqing Fu; Zhigang Tian; Haiming Wei
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

8.  A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis.

Authors:  Lara Bossini-Castillo; Carmen P Simeon; Lorenzo Beretta; Jasper C Broen; Madelon C Vonk; Raquel Ríos-Fernández; Gerard Espinosa; Patricia Carreira; María T Camps; Maria J Castillo; Miguel A González-Gay; Emma Beltrán; María del Carmen Freire; Javier Narváez; Carlos Tolosa; Torsten Witte; Alexander Kreuter; Annemie J Schuerwegh; Anna-Maria Hoffmann-Vold; Roger Hesselstrand; Claudio Lunardi; Jacob M van Laar; Meng May Chee; Ariane Herrick; Bobby Pc Koeleman; Christopher P Denton; Carmen Fonseca; Timothy Rdj Radstake; Javier Martin
Journal:  Arthritis Res Ther       Date:  2012-04-24       Impact factor: 5.156

9.  Human herpesviridae methods of natural killer cell evasion.

Authors:  Carl I Odom; David C Gaston; James M Markert; Kevin A Cassady
Journal:  Adv Virol       Date:  2012-07-08

Review 10.  Natural killer cells in human autoimmune disorders.

Authors:  Leslie A Fogel; Wayne M Yokoyama; Anthony R French
Journal:  Arthritis Res Ther       Date:  2013-07-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.